lencana Anda Rentang 52M $74–$122 38% of range Peringkat Analis BUY 23 analysts Target Harga $139 +49% upside P/E -29.8 ROE -450.9% Margin Laba Bersih -85.6%

RYTM Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $92.83
Kapitalisasi Pasar (MRQ) $6.39B
P/E (TTM) -29.8
EPS (TTM) $-3.11
Pendapatan (TTM) $240M
ROE (TTM) -450.9%
D/E Utang/Ekuitas (MRQ) 1.0
Rentang 52M $75–$122

RYTM Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang Rhythm Pharmaceuticals, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata
sektorHealthcare industriBiotechnology karyawan414 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$190M
2016-12-31 → 2025-12-31
EPS$-3.11
2019-12-31 → 2025-12-31
Arus Kas Bebas$-117M
2017-12-31 → 2025-12-31
Margin bersih-85.6%
2021-12-31 → 2025-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun RYTM rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) -29.8rata-rata 5T ≈-15.4 ≈-15.4 · ·
P/S (TTM) 26.6rata-rata 5T ≈65.8 ≈65.8 25.1 Lebih mahal
P/B (MRQ) 62.0rata-rata 5T ≈47.3 ≈47.3 18.6 Terlalu mahal
EV / EBITDA -31.1 · · ·
Price / FCF (Harga / FCF) -53.5rata-rata 5T ≈-23.7 ≈-23.7 · ·
Price / Cash Flow (Harga / Arus Kas) -53.9rata-rata 5T ≈-25.2 ≈-25.2 · ·
EV / Pendapatan (TTM) 25.7 · · ·
EV / FCF -51.1 · · ·
Harga / Nilai Buku Berwujud (MRQ) 65.1rata-rata 5T ≈60.7 ≈60.7 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata -0.46%
Laporan Berikutnya Nov 02, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Agu 3, 2026 $-0.73 $-0.84 12.8%
31 Maret 2026 $-0.83 $-0.87 4.6%
31 Des. 2025 $-0.73 $-0.84 12.9%
30 Sep. 2025 $-0.82 $-0.74 -11.1%
30 Juni 2025 $-0.75 $-0.69 -8.8%
31 Maret 2025 $-0.81 $-0.72 -13.2%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 17
Metrik Tren 2025202420232022202120202019201820172016
Revenue $190M$130M$77M$24M$3M$0$0$0$0$0
Cost of Revenue $19M$13M$9M$2M$599.0K·····
R&D Expense $167M$238M$135M$109M$104M$90M$109M$50M$23M$20M
SG&A Expense $195M$144M$118M$92M$68M$46M$37M$28M$10M$6M
Operating Expenses $382M$396M$262M$203M$173M$137M$146M$78M$32M$26M
Operating Income $-192M$-266M$-184M$-179M$-170M$-137M$-146M$-78M$-32M$-26M
Interest Expense ··$14M$5M······
Interest Income ····$447.0K$3M$5M$4M$566.0K$33.0K
Other Non-op $1M$2M$190.0K$-790.0K$100M$3M$5M$4M$-1M$33.0K
Pretax Income $-196M$-260M$-184M$-181M$-70M·····
Income Tax $497.0K$346.0K$564.0K·······
Net Income $-197M$-261M$-185M$-181M$-70M$-134M$-141M$-74M$-34M$-26M
EPS (Basic) $-3.11$-4.34$-3.20$-3.47$-1.40$-3.04$-3.86···
EPS (Diluted) $-3.11$-4.34$-3.20$-3.47$-1.40$-3.04$-3.86···
Shares (Basic) 64,984,36160,995,20457,673,12852,120,70149,600,29444,127,22036,422,450···
Shares (Diluted) 64,984,36160,995,20457,673,12852,120,70149,600,29444,127,22036,422,450···
EBITDA $-192M$-265M$-183M$-178M$-169M$-136M$-145M$-78M$-32M·
Neraca 27
Metrik Tren 2025202420232022202120202019201820172016
Cash & Equivalents $54M$89M$60M$128M$59M$101M$62M$50M$34M$7M
Short-term Investments $335M$231M$216M$206M$236M$72M$230M·$114M$4M
Receivables $26M$19M$15M$6M$1M·····
Inventory $26M$19M$9M$3M$111.0K·····
Prepaid Expense $26M$16M$9M$12M$12M$9M$10M$7M$3M$638.0K
Other Current Assets $10M$9M$7M$7M$4M$3M$4M$1M$1M$216.0K
Current Assets $467M$374M$308M$354M$308M$182M$302M$259M$151M$11M
PP&E (Net) $1M$632.0K$1M$2M$3M$3M$4M$1M$840.0K$930.0K
PP&E (Gross) $6M$5M$5M$5M$5M$5M$4M$2M$1M$1M
Accum. Depreciation $5M$5M$4M$3M$2M$1M$752.0K$809.0K$367.0K$144.0K
Intangibles $5M$6M$7M$8M$5M·····
Other Non-current Assets $3M$7M$15M$17M······
Total Assets $480M$392M$333M$382M$330M$187M$309M$260M$152M$12M
Accounts Payable $14M$12M$5M$5M$6M$5M$10M$8M$2M$2M
Accrued Liabilities $84M$63M$48M$33M$30M$13M$14M$6M$4M$3M
Current Liabilities $106M$116M$55M$40M$43M$18M$24M$14M$7M$5M
Capital Leases $3M$4M$490.0K$1M$2M·····
Total Liabilities $210M$228M$163M$118M$45M$21M$28M$14M$7M$5M
Long-term Debt $108M$110M········
Total Debt $108M$110M········
Common Stock $67.0K$61.0K$59.0K$56.0K$50.0K$44.0K$44.0K$34.0K$27.0K$10.0K
Paid-in Capital $1.49B$1.18B$1.06B$974M$813M$626M$606M$431M$255M$44M
Retained Earnings $-1.35B$-1.16B$-895M$-710M$-529M$-459M$-325M$-185M$-110M$-77M
AOCI $-796.0K$-39.0K$134.0K$-92.0K$-1.0K$49.0K····
Stockholders' Equity $139M$22M$170M$264M$284M$167M$281M$246M$145M$-33M
Liabilities + Equity $480M$392M$333M$382M$330M$187M$309M$260M$152M$12M
Shares Outstanding 67,205,32162,390,65459,426,55956,612,42950,283,57444,235,90343,996,75334,410,72527,284,14010,196,292
Arus Kas 16
Metrik Tren 2025202420232022202120202019201820172016
D&A $500.0K$700.0K$900.0K$896.0K$816.0K$690.0K$834.0K$442.0K$223.0K$144.0K
Stock-based Comp $67M$40M$33M$20M$21M$17M$12M$6M$2M$1M
Deferred Tax $0$0$0····$0$0$0
Amort. of Intangibles ··$855.0K$774.0K$342.0K·····
Other Non-cash $14M$106M$15M$-13M$-98M$-6M$5M$5M$2M·
Operating Cash Flow $-116M$-114M$-136M$-173M$-146M$-122M$-123M$-62M$-29M$-23M
CapEx $953.0K$0$47.0K$281.0K$434.0K$214.0K$3M$722.0K$133.0K$1M
Investing Cash Flow $-137M$-48M$-6M$28M$-62M$159M$-28M$-87M$-110M$-5M
Debt Issued $0$0$24M$72M······
Net Debt Issued $-20M$-13M$17M$72M······
Stock Issued $34M$39M$49M$131M$162M·$161M$163M$126M·
Net Stock Activity $34M$39M$49M$131M$162M·$161M$163M$126M·
Financing Cash Flow $218M$191M$74M$214M$166M$2M$163M$165M$167M·
Net Change in Cash $-35M$29M$-68M$68M$-42M$39M$13M$15M$28M$-28M
Free Cash Flow $-117M·$-136M$-174M$-146M$-122M$-126M$-63M$-30M·
Levered FCF ··$-150M·······
Profitabilitas 7
Metrik Tren 2025202420232022202120202019201820172016
Operating Margin -101.2%-204.0%-238.1%-757.9%-5391.9%·····
Net Margin -103.6%-200.3%-238.5%-766.2%-2207.1%·····
Pretax Margin -103.3%-200.0%-237.8%·······
EBITDA Margin -100.9%-203.5%-236.9%-754.1%-5366.0%·····
ROA -45.1%-71.9%-51.6%-50.9%-27.0%-54.1%-49.5%-36.0%-41.1%·
ROE -309.1%-1582.1%-100.6%-66.4%-23.0%-73.7%-65.4%-28.7%-60.2%·
ROIC -77.9%-202.1%-108.9%·······
Likuiditas & Solvabilitas 5
Metrik Tren 2025202420232022202120202019201820172016
Current Ratio 4.43.25.68.97.110.112.419.022.4·
Quick Ratio 3.92.95.38.56.89.62.63.622.0·
Debt / Equity 0.85.1········
LT Debt / Equity 0.75.0········
Interest Coverage ··-13.3-34.4······
Efisiensi 3
Metrik Tren 2025202420232022202120202019201820172016
Asset Turnover 0.40.40.20.10.00.00.00.00.0·
Inventory Turnover 0.91.01.61.410.8·····
Receivables Turnover 8.57.87.36.56.2·····
Per Saham 5
Metrik Tren 2025202420232022202120202019201820172016
Book Value / Share $2.07$0.35$2.86$4.67$5.65$3.76$6.39$7.16$5.31·
Revenue / Share $2.92$2.13$1.34$0.45$0.06·····
Cash Flow / Share $-1.78$-1.87$-2.36$-3.33$-2.94·····
Cash / Share $0.81$1.43$1.01$2.26$1.18$2.28$1.42$1.44$1.25·
EPS (TTM) $-3.11$-4.34$-3.20$-3.47$-1.40$-3.04$-3.86···
Tingkat Pertumbuhan 2
Metrik Tren 2025202420232022202120202019201820172016
Revenue YoY 45.8%68.1%227.6%649.5%······
Revenue CAGR 3Y 100.2%245.5%········
Valuasi (TTM) 14
Metrik Tren 2025202420232022202120202019201820172016
Revenue TTM $190M$130M$77M$24M$3M$0$0$0$0·
Net Income TTM $-197M$-261M$-185M$-181M$-70M$-134M$-141M$-74M$-34M·
Market Cap $7.19B$3.49B$2.73B$1.65B$502M$1.32B$1.01B$925M$793M·
Enterprise Value $6.91B$3.28B········
P/E -34.4-12.9-14.4-8.4-7.1-9.8-5.9···
P/S 37.926.835.369.7159.1·····
P/B 51.7160.716.16.21.87.93.63.85.5·
P / Tangible Book 53.8224.516.86.41.87.9····
P / Cash Flow -62.2-30.7-20.1-9.5-3.4-10.8-8.2-14.9-26.9·
P / FCF -61.7·-20.1-9.5-3.4-10.8-8.0-14.7-26.8·
EV / EBITDA -36.1-12.4········
EV / FCF -59.3·········
EV / Revenue 36.425.2········
Earnings Yield -2.9%-7.8%-7.0%-11.9%-14.0%-10.2%-16.8%···

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $190M $130M $77M $24M $3M
Margin Operasi % -101.2% -204.0% -238.1% -757.9% -5391.9%
Laba Bersih $-197M $-261M $-185M $-181M $-70M
EPS Dilusian $-3.11 $-4.34 $-3.20 $-3.47 $-1.40

Pemilik institusional (13F) 320 pengaju · $8.9B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 320
Nilai yang dipegang $8.9B
Posisi baru 59
Posisi yang keluar 38
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
59 (-7 vs Kuartal sebelumnya) 38 (-9 vs Kuartal sebelumnya) 106 (+7 vs Kuartal sebelumnya) 100 (+10 vs Kuartal sebelumnya) +3.0M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
RA CAPITAL MANAGEMENT, L.P. $740.218.912 6.666.837 8,32% Saham
BlackRock, Inc. $683.600.828 6.156.902 7,69% Saham
VANGUARD GROUP INC $664.816.448 6.210.916 7,48% Saham
BAKER BROS. ADVISORS LP $622.265.747 5.604.483 7,00% Saham
PRIMECAP MANAGEMENT CO/CA/ $351.837.748 3.168.853 3,96% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $348.289.452 3.136.895 3,92% Saham
VANGUARD CAPITAL MANAGEMENT LLC $333.753.626 3.005.977 3,75% Saham
JPMORGAN CHASE & CO $292.178.898 2.652.746 3,29% Saham
PERCEPTIVE ADVISORS LLC $287.156.334 2.586.295 3,23% Saham
STATE STREET CORP $285.728.722 2.573.529 3,21% Saham
WESTFIELD CAPITAL MANAGEMENT CO LP $245.220.303 2.208.595 2,76% Saham
GOLDMAN SACHS GROUP INC $236.105.516 2.126.502 2,65% Saham
FEDERATED HERMES, INC. $198.268.047 1.785.716 2,23% Saham
Polar Capital Holdings Plc $184.713.061 1.663.632 2,08% Saham
GEODE CAPITAL MANAGEMENT, LLC $170.320.392 1.533.698 1,92% Saham
Capital Research Global Investors $170.131.602 1.532.303 1,91% Saham
CITADEL ADVISORS LLC $140.303.282 1.263.652 1,58% Saham
Checkpoint Capital L.P. $131.681.580 1.186.000 1,48% Saham
Siren, L.L.C. $126.160.613 1.136.275 1,42% Saham
MORGAN STANLEY $123.492.178 1.112.240 1,39% Saham
FMR LLC $113.899.059 1.025.840 1,28% Saham
Pictet Asset Management Holding SA $106.252.095 957.785 1,19% Saham
Woodline Partners LP $84.259.668 758.891 0,95% Saham
JANUS HENDERSON GROUP PLC $79.886.248 918.153 0,90% Saham
ALLIANCEBERNSTEIN L.P. $77.814.059 894.723 0,87% Saham
Clearbridge Investments, LLC $77.329.368 696.473 0,87% Saham
Rock Springs Capital Management LP $76.899.156 692.598 0,86% Saham
NORGES BANK $76.149.259 685.844 0,86% Saham
FRANKLIN RESOURCES INC $64.067.973 577.033 0,72% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $61.370.500 552.738 0,69% Saham
Integral Health Asset Management, LLC $61.066.500 550.000 0,69% Saham
Invesco Ltd. $60.319.379 543.271 0,68% Saham
NORTHERN TRUST CORP $59.993.061 540.332 0,67% Saham
WELLINGTON MANAGEMENT GROUP LLP $54.265.580 488.747 0,61% Saham
VANGUARD FIDUCIARY TRUST CO $49.488.625 445.723 0,56% Saham
LOOMIS SAYLES & CO L P $48.198.345 434.102 0,54% Saham
Candriam S.C.A. $48.032.508 433.025 0,54% Saham
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $47.089.907 541.450 0,53% Saham
Squarepoint Ops LLC $46.956.919 422.921 0,53% Saham
Point72 Asset Management, L.P. $45.989.736 414.210 0,52% Saham
Sofinnova Investments, Inc. $45.303.238 408.027 0,51% Saham
AMERIPRISE FINANCIAL INC $44.593.674 401.634 0,50% Saham
ADAGE CAPITAL PARTNERS GP, L.L.C. $44.078.910 397.000 0,50% Saham
Bank of New York Mellon Corp $43.750.776 394.044 0,49% Saham
BRAIDWELL LP $42.316.642 381.128 0,48% Saham
Artisan Partners Limited Partnership $39.395.220 354.816 0,44% Saham
BANK OF AMERICA CORP /DE/ $36.136.934 325.470 0,41% Saham
ORBIMED ADVISORS LLC $35.851.587 322.900 0,40% Saham
MILLENNIUM MANAGEMENT LLC $35.165.311 316.719 0,40% Saham
SILVERARC CAPITAL MANAGEMENT, LLC $34.581.515 311.461 0,39% Saham

Tampilkan semua 320 pemilik institusional →

Aktivis & pemilik 5%+ 7 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
30 April 2024 · Pengajuan awal · SEC
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd., C2 Life Sciences LLC, Perceptive Discovery Fund LP, Joseph Edelman ×3 pengajuan 17 April 2024 · Pengajuan awal · SEC
New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Forest Baskett, Patrick J. Kerins, Scott D. Sandell ×2 pengajuan 29 Maret 2023 · Pengajuan awal Investasi pasif SEC
MPM BioVentures V, L.P., MPM Asset Management Investors BV5 LLC, MPM BioVentures V GP LLC, MPM BioVentures V LLC, Ansbert Gadicke, Luke Evnin, Todd Foley ×2 pengajuan 26 Juni 2020 · Pengajuan awal · SEC
Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan 5 Feb. 2020 · Pengajuan awal · SEC
Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan 12 Feb. 2019 · Pengajuan awal Investasi pasif SEC
OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×5 pengajuan 10 Agu 2018 · Pengajuan awal · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 37 orang dalam · 16 pejabat · 12 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
David P Meeker President and CEO 14 Sep. 2026 M 239.258 0 5 $-5.133.559
Keith Michael Gottesdiener CEO & President 9 Maret 2020 M 558.250 0 0 $0
Hunter C Smith Chief Financial Officer 31 Agu 2026 M 114.024 0 26 $-8.837.032
Manher Joshi Chief Medical Officer 17 Agu 2026 A · 0 0 $0
Alastair Garfield Chief Scientific Officer 13 Agu 2026 S 2.295 0 4 $-912.697
Joseph Shulman Chief Technical Officer 13 Agu 2026 M 15.915 0 6 $-3.672.703
Jennifer Chien EVP, Head of North America 13 Agu 2026 M 0 0 1 $-8.901.395
Yann Mazabraud EVP, Head of International 12 Agu 2026 M 55.655 0 6 $-6.620.591
Christopher Paul German Corporate Controller & CAO 15 Mei 2026 M 0 0 2 $-930.921
Pamela J. Cramer Chief Human Resources Officer 11 Feb. 2026 A 29.376 0 4 $-2.987.366
William T. Roberts Chief Accounting Officer 29 Maret 2023 M 7.872 0 0 $0
Linda Shapiro Manning Chief Medical Officer 9 Feb. 2022 A · 0 0 $0
Murray Stewart Chief Medical Officer 11 Feb. 2021 A · 0 0 $0
Nithya Desikan Chief Commercial Officer 31 Agu 2020 M 43.602 0 0 $0
Leonardus H.T. Van Der Ploeg Chief Scientific Officer 31 Mei 2019 M 42.339 0 0 $0
Fred T. Fiedorek Chief Medical Officer 14 Feb. 2018 A · 0 0 $0
Lynn A. Tetrault Direktur 24 Juni 2026 A 11.712 0 1 $-3.711.840
Stuart A Arbuckle Direktur 24 Juni 2026 A 11.712 0 0 $0
Christophe Jean Direktur 24 Juni 2026 A 11.712 0 0 $0
Jennifer L Good Direktur 24 Juni 2026 A 11.712 0 0 $0
David W J Mcgirr Direktur 24 Juni 2026 A 11.712 0 0 $0
Kimberly J Popovits Direktur 1 April 2026 A · 0 0 $0
Edward T. Mathers Direktur 12 Maret 2026 J 14.168 0 0 $0
Camille L Bedrosian Direktur 24 Juni 2025 A 7.000 0 0 $0
Todd Foley Direktur 15 Maret 2021 S 909.258 0 0 $0
Neil Exter Direktur 6 Juni 2018 A 0 0 0 $0
Hadley Harbor Master Investors (Cayman) L.P. Pemilik 10% 10 Okt. 2017 C 545.256 0 0 $0
Ravi Viswanathan Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
Ipsen, S.A. Pemilik 10% 10 Okt. 2017 C 833.099 0 0 $0
Forest Baskett Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
Patrick J. Kerins Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
David M Mott Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
James M Barrett Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
Peter J Barris Pemilik 10% 10 Okt. 2017 C 4.909.956 0 0 $0
Pfizer Inc. Pemilik 10% 10 Okt. 2017 C 1.427.639 0 0 $0
Simon Kelner · 11 Feb. 2021 A · 0 0 $0
Scott D. Sandell · 10 Okt. 2017 C 4.909.956 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 35 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
MEDI · Harbor ETF Trust 4,02% 16.680 NS 31 Juli 2026 N-PORT
BBP · ETFis Series Trust I 1,55% 15.357 NS 31 Juli 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,79% 39.370 NS 31 Juli 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0,59% 25.494 SH 2 Okt. 2026 Harian
FNY · First Trust Exchange-Traded AlphaDE… 0,57% 33.067 NS 31 Juli 2026 N-PORT
IBB · iShares Trust 0,50% 507.659 SH 11 Sep. 2026 Harian
IBBQ · Invesco Exchange-Traded Fund Trust … 0,43% 4.873 SH 2 Okt. 2026 Harian
IWO · iShares Trust 0,37% 517.925 SH 11 Sep. 2026 Harian
VTWG · VANGUARD SCOTTSDALE FUNDS 0,36% 59.038 SH 19 Agu 2026 Harian
PWS · Pacer Funds Trust 0,22% 538 NS 31 Juli 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,22% 1.927 NS 31 Juli 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0,21% 908.106 SH 19 Agu 2026 Harian
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 14.383 NS 31 Juli 2026 N-PORT
FNX · First Trust Exchange-Traded AlphaDE… 0,20% 27.831 NS 31 Juli 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,19% 317.548 SH 19 Agu 2026 Harian
IWM · iShares Trust 0,18% 1.410.048 SH 11 Sep. 2026 Harian
ISCG · iShares Trust 0,18% 16.741 SH 11 Sep. 2026 Harian
RSSL · Global X Funds 0,18% 26.425 NS 31 Juli 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,17% 9.930 NS 31 Juli 2026 N-PORT
VB · VANGUARD INDEX FUNDS 0,09% 1.571.929 SH 19 Agu 2026 Harian
VHT · VANGUARD WORLD FUND 0,09% 164.403 SH 19 Agu 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,08% 715.506 SH 19 Agu 2026 Harian
FHLC · FIDELITY COVINGTON TRUST 0,08% 25.957 NS 31 Juli 2026 N-PORT
WSML · iShares Trust 0,05% 3.457 SH 11 Sep. 2026 Harian
ESML · iShares Trust 0,05% 14.054 SH 11 Sep. 2026 Harian
PRFZ · Invesco Exchange-Traded Fund Trust 0,04% 12.237 SH 2 Okt. 2026 Harian
TILT · FlexShares Trust 0,01% 3.058 NS 31 Juli 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,01% 2.177.236 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 4.502 SH 19 Agu 2026 Harian
ESGV · VANGUARD WORLD FUND 0,01% 12.173 SH 19 Agu 2026 Harian
ITOT · iShares Trust 0,01% 83.940 SH 11 Sep. 2026 Harian
IWV · iShares Trust 0,01% 14.197 SH 11 Sep. 2026 Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 43.280 SH 19 Agu 2026 Harian
ISCB · iShares Trust · 2.395 SH 11 Sep. 2026 Harian
SMLF · iShares Trust · 49.815 SH 11 Sep. 2026 Harian

RYTM Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 23 analis BELI
Target median $143.00 +54,0%
8 34,8% Beli Kuat
12 52,2% Beli
3 13,0% Tahan
0 0,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

17 analis · 2026-09-29

Target rata-rata $138.59 +49,3%

← Di bawah semua target Harga saat ini $92.83
Rendah$105.00 Rata-rata$138.59 Tinggi$160.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
RYTM $7.19B -34.4 45.8% -103.6% -309.1% ·
IMVT $5.07B -9.0 229.2% · -73.7% ·
IOVA $1.12B -2.5 60.6% -148.4% -56.0% ·
GRAL $3.45B -7.7 17.2% -277.5% -16.7% ·
CGON $3.35B -20.0 254.7% -3985.0% -22.6% ·
KOD $1.73B -6.5 · · -202.0% ·
SRRK $4.78B -13.4 · · -157.9% ·
ORKA $1.48B -3.3 · · -25.9% ·
MIRM $4.10B -168.1 54.7% -4.5% -8.2% ·
COGT $5.72B -16.4 · · -83.1% ·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23
Mengapa Saham Rhythm Pharmaceuticals Menang pada Selasa Nasdaq · 4 bulan, 3 minggu lalu Apakah Rhythm Pharmaceuticals, Inc. (RYTM) Saham yang Baik untuk Dibeli Sekarang? Yahoo Finance · 5 bulan, 1 minggu lalu Rhythm Mendapatkan Persetujuan Obesitas Baru; Bagaimana Ia Unggul Di Tempat Lilly, Novo 'Gagal' Yahoo Finance · 6 bulan, 1 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 4, 2026